‘Patent to patient’ time is too long and rising for cancer meds

Highly innovative cancer drugs took longer to reach NHS patients than more conventional treatments Related items fromOnMedica NHS must improve access to screening to save lives Cancer strategies failed to improve one-year survival One in four cancer patients experience delayed diagnoses UK cancer survival improved, but lags behind similar nations Is crowdfunding for cancer patients paying for ‘quackery’?
Source: OnMedica Latest News - Category: UK Health Source Type: news